From: Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014
1995–1999 | 2000–2004 | 2005–2009 | 2010–2014a | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1-year RSR | 5-year RSR | 95%CI | 1-year RSR | 5-year RSR | 95%CI | 1-year RSR | 5-year RSR | 95%CI | 1-year RSR | 5-year RSR | 95%CI | |
Total | 80 | 59 | 55–62 | 84 | 64 | 60–68 | 86 | 69 | 66–72 | 84 | 67 | 64–70 |
Total (age-standardized) | 78 | 58 | 54–62 | 83 | 62 | 58–66 | 84 | 67 | 63–70 | 83 | 66 | 62–69 |
Age at diagnosis | ||||||||||||
15–29 | 94 | 77 | 49–91 | 93 | 83 | 64–93 | 86 | 80 | 60–90 | 97 | 89 | 70–97 |
30–39 | 85 | 67 | 57–75 | 95 | 82 | 73–88 | 98 | 91 | 84–95 | 96 | 89 | 82–94 |
40–49 | 84 | 63 | 55–69 | 88 | 71 | 64–77 | 91 | 76 | 71–81 | 92 | 80 | 74–85 |
50–59 | 85 | 59 | 52–66 | 86 | 58 | 49–65 | 88 | 67 | 59–73 | 83 | 61 | 54–67 |
60–69 | 78 | 60 | 51–68 | 81 | 58 | 50–67 | 88 | 66 | 57–74 | 84 | 66 | 57–73 |
70+ | 64 | 43 | 33–53 | 70 | 48 | 37–58 | 61 | 42 | 33–52 | 67 | 41 | 32–50 |
Morphology | ||||||||||||
AC | 79 | 55 | 40–69 | 88 | 66 | 52–78 | 85 | 65 | 54–75 | 86 | 63 | 52–72 |
SCC | 83 | 61 | 57–65 | 86 | 65 | 61–69 | 88 | 72 | 68–75 | 87 | 71 | 68–75 |
NOS | 51 | 42 | 27–55 | 52 | 33 | 17–52 | 50 | 38 | 22–54 | 41 | 30 | 17–44 |
Stageb | ||||||||||||
I | 100 | 96 | 92–98 | 100 | 98 | 95–100 | ||||||
II | 96 | 72 | 63–80 | 95 | 74 | 65–82 | ||||||
III | 81 | 52 | 44–59 | 88 | 57 | 49–64 | ||||||
IV | 47 | 24 | 16–33 | 53 | 22 | 15–29 | ||||||
Unknown | 66 | 49 | 37–61 | 65 | 43 | 33–53 |